JAMDA
August 24, 2019
Showing 6721 - 6730 of 8374 results
JAMDA
April 30, 2014
Sarcopenia: There Is a Need for Some Steps Forward
JAMDA
July 19, 2022
Sarcopenic Dysphagia Is Associated With Mortality in Institutionalized Older Adults
To estimate mortality associated with sarcopenic dysphagia.
JAMDA
April 13, 2023
Sarcopenic Obesity and Risk of Disability in Community-Dwelling Japanese Older Adults: A 5-Year Longitudinal Study
Previous studies have indicated that sarcopenic obesity is a risk factor for disability onset. However, these studies had disparities in terms of criteria for sarcopenia, study design, or study population. No longitudinal study has investigated the effect of sarcopenic obesity on disability onset in an Asi...
JAMDA
July 2, 2026
Sarcopenic Obesity in Older Korean Adults: Comparison of 2 Diagnostic Frameworks and Functional Outcomes
To compare the prevalence and diagnostic agreement of sarcopenic obesity (SO) defined by the European Society for Clinical Nutrition and Metabolism (ESPEN)/European Association for the Study of Obesity (EASO) framework and Asian Working Group for Sarcopenia (AWGS) criteria and to examine associations with ...
JAMDA
May 20, 2020
Sarcopenic Obesity Is Associated With Activities of Daily Living and Home Discharge in Post-Acute Rehabilitation
The aim of this study was to evaluate the effect of sarcopenic obesity on activities of daily living and home discharge rates in adults undergoing convalescent rehabilitation. In addition, we evaluated diagnostic criteria for sarcopenic obesity to predict outcomes.
JAMDA
April 17, 2018
Sarcopenic Obesity Revisited: Insights From the Mr and Ms Os Cohort
Following the concept of a metabolic load-capacity model, we propose the use of appendicular skeletal muscle mass (ASM) to total body fat (TBF) ratio in predicting 4-year physical limitations, physical performance measures, 6-year incident diabetes and cardiovascular diseases, and 12-year mortality. ...
JAMDA
May 5, 2016
Sarcopenic Obesity, Functional Outcomes, and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease
Both loss of muscle mass (ie, sarcopenia) and obesity adversely impact clinically important outcomes in patients with chronic obstructive pulmonary disease (COPD). Currently, there are only a few studies in patients with COPD with sarcopenia and concurrent obesity, termed sarcopenic obesity (SO).
JAMDA
August 27, 2021
SARS-CoV-2 and Wisconsin Nursing Homes: Temporal Dynamics During the COVID-19 Pandemic
Evidence suggests that quality, location, and staffing levels may be associated with COVID-19 incidence in nursing homes. However, it is unknown if these relationships remain constant over time. We describe incidence rates of COVID-19 across Wisconsin nursing homes while examining factors associated with t...
JAMDA
September 4, 2021
SARS-CoV-2 B 1.1.7 Variant Outbreak in a Fully Vaccinated Nursing Home—Madrid, June 2021
